Alexis Borisy, Third Rock Ventures partner, discusses the fund's biotech investment strategy on "Bloomberg Technology." (Source: Bloomberg)
Alexis Borisy, Third Rock Ventures partner, discusses the fund's biotech investment strategy on "Bloomberg Technology." (Source: Bloomberg)